(Press-News.org) ROCHESTER, Minn. -- Researchers at Mayo Clinic Cancer Center have developed new guidelines to treat recently diagnosed multiple myeloma patients who are not participating in clinical trials. The guidelines give physicians practical, easy to follow recommendations for providing initial therapy, stem cell transplant and maintenance therapy. The guidelines are published in the current issue of the journal Mayo Clinic Proceedings and represent a consensus opinion of hematologists at Mayo Clinic Cancer Center sites in Minnesota, Florida and Arizona.
"Multiple myeloma is an incurable blood cancer that affects more than 20,000 people in the U.S. each year," says lead author Joseph Mikhael, M.D. a hematologist at Mayo Clinic in Arizona. "Over the past decade we have made great progress in understanding the disease, developing drug therapies and increasing overall survival. However, as a medical community we haven't done as good a job at optimizing therapy based on a patient's individual risk factors."
Dr. Mikhael says the new guidelines will help patients with low-risk disease avoid the harsh side effects of therapy and will reserve more intense therapy for patients with aggressive disease.
Among the guidelines:
A strong recommendation to enroll patients in clinical trials as the first option for therapy or supportive care.
Separating patients by risk into three groups to make the most of new drug therapy: high risk, intermediate risk and low risk. Previous guidelines included only two groups: high risk and standard risk.
Adding factors to assess the risk the multiple myeloma poses to the patient, including use of gene expression profiling to help identify patients with high-risk disease.
Greater emphasis on delaying stem cell transplants to take advantage of improved chemotherapy, resulting in better responses.
Maintenance therapy using drugs such as lenalidomide and bortezomib that balance benefit with short- and long-term toxicity.
###
Co-authors include David Dingli, M.D., Ph.D.; Vivek Roy, M.D.; Craig Reeder, M.D.; Francis Buadi, M.D.; Suzanne Hayman, M.D.; Angela Dispenzieri, M.D.; Rafael Fonseca, M.D.; Taimur Sher, M.D.; Robert Kyle, M.D.; Yi Lin, M.D., Ph.D.; Stephen Russell, M.D., Ph.D.; Shaji Kumar, M.D.; Leif Bergsagel, M.D.; Steven Zeldenrust, M.D., Ph.D.; Nelson Leung, M.D.; Matthew Drake, M.D., Ph.D.; Prashant Kapoor, M.D.; Stephen Ansell, M.D., Ph.D.; Thomas Witzig, M.D.; John Lust, M.D., Ph.D.; Robert Dalton, M.D.; Morie Gertz, M.D.; Keith Stewart, M.B.Ch.B.; Vincent Rajkumar, M.D.; Asher Chanan-Khan, M.D.; and Martha Lacy, M.D., all of Mayo Clinic.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Mayo Clinic: New multiple myeloma treatment guidelines personalize therapy for patients
2013-04-01
ELSE PRESS RELEASES FROM THIS DATE:
Research deciphers HIV attack plan
2013-04-01
LOS ALAMOS, N. M., March 29, 2013—A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses that successfully pass from a chronically infected person to a new individual are both remarkably resistant to a powerful initial human immune-response mechanism, and they are blanketed in a greater amount of envelope protein that helps them access and enter host cells.
These findings will help inform vaccine design and interpretation of vaccine trials, ...
Newly approved blood thinner may increase susceptibility to some viral infections
2013-04-01
CHAPEL HILL, N.C. – A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
For the past 50 years, people with the heartbeat irregularity, atrial fibrillation, and others at increased risk for forming potentially life-threatening blood clots have been given the ...
Congestion in the Earth's mantle
2013-04-01
Jena (Germany) The Earth is dynamic. What we perceive as solid ground beneath our feet, is in reality constantly changing. In the space of a year Africa and America are drifting apart at the back of the Middle Atlantic for some centimeters while the floor of the Pacific Ocean is subducted underneath the South American Continent. "In 100 million years' time Africa will be pulled apart and North Australia will be at the equator," says Prof. Dr. Falko Langenhorst from the Friedrich Schiller University Jena (Germany). Plate tectonics is leading to a permanent renewal of the ...
Researchers discover new clues about how amyotrophic lateral sclerosis develops
2013-04-01
Johns Hopkins scientists say they have evidence from animal studies that a type of central nervous system cell other than motor neurons plays a fundamental role in the development of amyotrophic lateral sclerosis (ALS), a fatal degenerative disease. The discovery holds promise, they say, for identifying new targets for interrupting the disease's progress.
In a study described online in Nature Neuroscience, the researchers found that, in mice bred with a gene mutation that causes human ALS, dramatic changes occurred in oligodendrocytes — cells that create insulation for ...
New models predict drastically greener Arctic in coming decades
2013-04-01
New research predicts that rising temperatures will lead to a massive "greening," or increase in plant cover, in the Arctic. In a paper published on March 31 in Nature Climate Change, scientists reveal new models projecting that wooded areas in the Arctic could increase by as much as 50 percent over the next few decades. The researchers also show that this dramatic greening will accelerate climate warming at a rate greater than previously expected.
"Such widespread redistribution of Arctic vegetation would have impacts that reverberate through the global ecosystem," said ...
Pitt team finds immunity protein that ramps up inflammation, and agents that can block it
2013-04-01
Scientists at the University of Pittsburgh School of Medicine have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia. They reported their findings today in Nature Immunology.
Pneumonia and other infections sometimes provoke an inflammatory response from the body that is more detrimental than the disease-causing bacteria, said senior author Rama Mallampalli, M.D, professor and vice chair for research, Department ...
Is guided self-help effective in treating childhood obesity?
2013-04-01
It is known that family-based treatment that combines nutrition and exercise education, along with behavior modification, is a good approach to help children lose weight. But clinic-based weight-control programs for childhood obesity are not accessible to many families, due to issues such as cost or time commitment.
Initial studies at the University of California, San Diego School of Medicine indicate that a self-help treatment program for overweight children and their parents, guided by clinical experts, may be an effective solution. The study, led by Kerri Boutelle, ...
Varicella vaccine has long-term effectiveness against chicken pox
2013-04-01
OAKLAND, Calif., April 1, 2013 – Chicken pox, the childhood affliction of earlier generations, has been largely neutralized by the varicella vaccine, according to a new study by the Kaiser Permanente Vaccine Study Center, which appears in the current online issue of Pediatrics.
The 14-year study followed 7,585 children who were vaccinated in 1995, when they were 12 to 23 months old, to assess the long-term effectiveness of the vaccine and the impact on the epidemiology of varicella (chicken pox) and herpes zoster (shingles). Researchers also observed the impact of the ...
New technique shows promise in restoring near vision without glasses
2013-04-01
Philadelphia, Pa. (April 1, 2013) - By middle age, most people have age-related declines in near vision (presbyopia) requiring bifocals or reading glasses. An emerging technique called hyperopic orthokeratology (OK) may provide a new alternative for restoring near vision without the need for glasses, according to a study, "Refractive Changes from Hyperopic Orthokeratology Monovision in Presbyopes", appearing in the April issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins ...
Jogging Stroller Reviews
2013-04-01
Every month, tens of thousands of people are searching for jogging stroller reviews online. Unfortunately, only a handful of websites currently provide legitimate reviews, making it difficult for athletic parents to find unbiased information.
"It's a shame; it's hard for athletic parents to find information about jogging strollers. You never know whether you're going to make the right choice when it comes to safety and reliability" says Henry Stinson, one of the staff members at the newly launched website, BestJoggingStrollerReviews.org
The site provides ...